icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
Cwf8rbn7UsjRCps7